Metropolitan Life Insurance CO Alaunos Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

$253 Million
Q2 2024

45 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$0.62 - $1.17 $16,003 - $30,200	-25,812 Closed	0 $0
Q4 2021 Jun 21, 2023	BUY	$1.09 - $1.89 $28,135 - $48,784	25,812 New	25,812 $28,000
Q4 2021 Mar 30, 2023	SELL	$1.09 - $1.89 $4,469 - $7,749	-4,100 Reduced 13.71%	25,812 $28,000
Q4 2021 Feb 15, 2022	SELL	$1.09 - $1.89 $4,469 - $7,749	-4,100 Reduced 13.71%	25,812 $28,000
Q3 2021 Jun 21, 2023	BUY	$1.44 - $2.73 $43,073 - $81,659	29,912 New	29,912 $54,000
Q3 2021 Mar 30, 2023	SELL	$1.44 - $2.73 $42,132 - $79,877	-29,259 Reduced 49.45%	29,912 $54,000
Q3 2021 Nov 15, 2021	SELL	$1.44 - $2.73 $42,132 - $79,877	-29,259 Reduced 49.45%	29,912 $54,000
Q2 2021 Jun 21, 2023	BUY	$2.63 - $3.67 $155,619 - $217,157	59,171 New	59,171 $156,000
Q2 2021 Mar 30, 2023	SELL	$2.63 - $3.67 $1,730 - $2,414	-658 Reduced 1.1%	59,171 $156,000
Q2 2021 Aug 16, 2021	BUY	$2.63 - $3.67 $155,461 - $216,937	59,111 Added 98518.33%	59,171 $156,000
Q1 2021 Jun 26, 2023	BUY	$2.82 - $5.6 $168,717 - $335,042	59,829 New	59,829 $215 Million
Q1 2021 Mar 30, 2023	SELL	$2.82 - $5.6 $651 - $1,293	-231 Reduced 0.38%	59,829 $215,000
Q1 2021 May 14, 2021	SELL	$2.82 - $5.6 $169,200 - $336,000	-60,000 Reduced 99.9%	60 $215,000
Q4 2020 Jun 22, 2023	BUY	$2.09 - $3.09 $125,525 - $185,585	60,060 New	60,060 $151,000
Q4 2020 Mar 30, 2023	SELL	$2.09 - $3.09 $2,978 - $4,403	-1,425 Reduced 2.32%	60,060 $151,000
Q4 2020 Feb 16, 2021	SELL	$2.09 - $3.09 $2,978 - $4,403	-1,425 Reduced 2.32%	60,060 $151,000
Q3 2020 Jun 26, 2023	BUY	$2.39 - $3.43 $146,949 - $210,893	61,485 New	61,485 $154,000
Q3 2020 Mar 30, 2023	SELL	$2.39 - $3.43 $14,414 - $20,686	-6,031 Reduced 8.93%	61,485 $154,000
Q3 2020 Nov 13, 2020	SELL	$2.39 - $3.43 $14,414 - $20,686	-6,031 Reduced 8.93%	61,485 $155,000
Q2 2020 Jun 26, 2023	BUY	$2.2 - $3.71 $148,535 - $250,484	67,516 New	67,516 $221,000
Q2 2020 Mar 30, 2023	BUY	$2.2 - $3.71 $65,597 - $110,621	29,817 Added 79.09%	67,516 $221,000
Q2 2020 Aug 14, 2020	BUY	$2.2 - $3.71 $65,597 - $110,621	29,817 Added 79.09%	67,516 $221,000
Q1 2020 Jul 12, 2023	BUY	$1.9 - $4.98 $79,497 - $208,368	41,841 New	41,841 $102,000
Q1 2020 Mar 30, 2023	SELL	$1.9 - $4.98 $8,553 - $22,419	-4,502 Reduced 10.67%	37,699 $92,000
Q1 2020 May 15, 2020	SELL	$1.9 - $4.98 $8,553 - $22,419	-4,502 Reduced 10.67%	37,699 $92,000
Q4 2019 Jul 12, 2023	BUY	$3.95 - $5.35 $166,693 - $225,775	42,201 New	42,201 $199,000
Q4 2019 Mar 30, 2023	SELL	$3.95 - $5.35 $47,609 - $64,483	-12,053 Reduced 22.22%	42,201 $199,000
Q4 2019 Feb 14, 2020	SELL	$3.95 - $5.35 $47,609 - $64,483	-12,053 Reduced 22.22%	42,201 $199,000
Q3 2019 Jul 12, 2023	BUY	$4.13 - $6.94 $224,069 - $376,522	54,254 New	54,254 $232,000
Q3 2019 Mar 30, 2023	BUY	$4.13 - $6.94 $38,999 - $65,534	9,443 Added 21.07%	54,254 $232,000
Q3 2019 Nov 14, 2019	BUY	$4.13 - $6.94 $38,999 - $65,534	9,443 Added 21.07%	54,254 $232,000
Q2 2019 Jul 12, 2023	BUY	$3.98 - $6.2 $185,058 - $288,281	46,497 New	46,497 $271,000
Q1 2019 Jul 13, 2023	BUY	$2.0 - $4.4 $89,622 - $197,168	44,811 New	44,811 $172,000
Q1 2019 Mar 30, 2023	BUY	$2.0 - $4.4 $89,622 - $197,168	44,811 New	44,811 $172,000
Q1 2019 May 16, 2019	BUY	$2.0 - $4.4 $53,402 - $117,484	26,701 Added 147.44%	44,811 $172,000
Q1 2019 May 15, 2019	SELL	$2.0 - $4.4 $52,660 - $115,852	-26,330 Reduced 59.25%	18,110 $125,000
Q4 2018 Jul 13, 2023	BUY	$1.61 - $3.62 $71,548 - $160,872	44,440 New	44,440 $83,000
Q4 2018 Feb 14, 2019	BUY	$1.61 - $3.62 $55,810 - $125,487	34,665 Added 354.63%	44,440 $83,000
Q3 2018 Jul 13, 2023	BUY	$2.26 - $3.27 $100,434 - $145,318	44,440 New	44,440 $142 Million
Q3 2018 Nov 14, 2018	SELL	$2.26 - $3.27 $78,342 - $113,354	-34,665 Reduced 78.0%	9,775 $31,000
Q2 2018 Aug 15, 2018	BUY	$3.02 - $4.94 $11,113 - $18,179	3,680 Added 9.03%	44,440 $0
Q1 2018 May 15, 2018	BUY	$3.46 - $5.14 $24,870 - $36,946	7,188 Added 21.41%	40,760 $0
Q4 2017 Feb 15, 2018	BUY	$4.0 - $6.54 $134,288 - $219,560	33,572 New	33,572 $139,000
Q3 2017 Nov 14, 2017	SELL	$4.99 - $6.57 $442,697 - $582,870	-88,717 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	88,717	88,717 $552,000

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $443M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account